Citigroup
PGEN icon

Citigroup’s Precigen PGEN Stock Holding History

Citigroup’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,600
Closed -$67K – 7112
2020
Q4 		$67K Hold
6,600
– – ﹤0.01% 5834
2020
Q3 		$23K Hold
6,600
– – ﹤0.01% 6097
2020
Q2 		$33K Sell
6,600
-1,600
-20% -$5.44K ﹤0.01% 6259
2020
Q1 		$28K Sell
8,200
-22,700
-73% -$98K ﹤0.01% 6459
2019
Q4 		$169K Sell
30,900
-11,500
-27% -$64.7K ﹤0.01% 5334
2019
Q3 		$243K Sell
42,400
-34,200
-45% -$232K ﹤0.01% 4990
2019
Q2 		$587K Buy
76,600
+4,700
+7% +$25.3K ﹤0.01% 4252
2019
Q1 		$378K Buy
71,900
+27,500
+62% +$191K ﹤0.01% 4485
2018
Q4 		$290K Sell
44,400
-2,600
-6% -$29.1K ﹤0.01% 4657
2018
Q3 		$809K Sell
47,000
-6,100
-11% -$90.7K ﹤0.01% 3739
2018
Q2 		$740K Sell
53,100
-2,600
-5% -$43.9K ﹤0.01% 3679
2018
Q1 		$854K Buy
55,700
+5,800
+12% +$82.9K ﹤0.01% 3411
2017
Q4 		$575K Sell
49,900
-26,500
-35% -$395K ﹤0.01% 3958
2017
Q3 		$1.45M Buy
76,400
+5,600
+8% +$115K ﹤0.01% 2986
2017
Q2 		$1.71M Buy
70,800
+11,900
+20% +$261K ﹤0.01% 2753
2017
Q1 		$1.17M Buy
58,900
+16,320
+38% +$364K ﹤0.01% 3048
2016
Q4 		$1.02M Sell
42,580
-16,245
-28% -$452K ﹤0.01% 3665
2016
Q3 		$1.63M Sell
58,825
-36,727
-38% -$971K ﹤0.01% 2710
2016
Q2 		$2.33M Buy
95,552
+8,374
+10% +$238K ﹤0.01% 2231
2016
Q1 		$2.93M Buy
87,178
+44,598
+105% +$1.4M ﹤0.01% 2086
2015
Q4 		$1.27M Buy
42,580
+21,088
+98% +$711K ﹤0.01% 2874
2015
Q3 		$677K Buy
21,492
+9,081
+73% +$443K ﹤0.01% 3455
2015
Q2 		$600K Buy
12,411
+8,958
+259% +$378K ﹤0.01% 3545
2015
Q1 		$150K Buy
+3,453
New +$124K ﹤0.01% 4752

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Citigroup's PGEN Position: Q1 2026 in Review

Citigroup increased its Precigen (PGEN) stake by 230% in Q1 2026, buying an estimated $1.09M and bringing the position to 381,365 shares worth $1.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2864.

Citigroup first reported a position in PGEN in Q3 2013 and has held it in 51 quarters since. The position peaked at $3.42M in Q1 2021. 205 funds tracked by Wall St. Rank hold PGEN as of Q1 2026.

  • Citigroup held 381,365 shares of Precigen worth $1.48M as of Q1 2026.
  • Citigroup bought 265,658 Precigen shares in Q1 2026, an estimated $1.09M.
  • Precigen made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2864 holding.
  • Citigroup first reported a position in Precigen in Q3 2013 and has held it in 51 quarters since.
  • Citigroup's Precigen position peaked at $3.42M in Q1 2021.
  • 205 funds tracked by Wall St. Rank held Precigen as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.